GTN Sorbitrate-CR

Name: GTN Sorbitrate-CR Price Comparison: Uses, Dosage, Form & Side Effects
Creator: gmedication.com
Published: 2021-11-01T10:10:10+00:00

Was this drug effective for your ailment?

Here is the some steps to help you to save money on GTN Sorbitrate-CR purchase.

Read drug prescription

What is GTN Sorbitrate-CR
GTN Sorbitrate-CR side effects
GTN Sorbitrate-CR dosing

Select the most affordable brand or generic drug
Frequently asked Questions

Who should not take GTN Sorbitrate-CR?
How should I take GTN Sorbitrate-CR?
What other drugs will affect GTN Sorbitrate-CR?

GTN Sorbitrate-CR reviews

Read drug prescription

What is GTN Sorbitrate-CR

GTN Sorbitrate-CR is in a group of drugs called nitrates. GTN Sorbitrate-CR dilates blood vessels, making it easier for blood to flow through them and easier for the heart to pump.
GTN Sorbitrate-CR is used to treat or prevent attacks of chest pain (angina).
GTN Sorbitrate-CR may also be used for purposes not listed in GTN Sorbitrate-CR guide.

GTN Sorbitrate-CR side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Seek emergency medical attention if you have symptoms of a heart attack, such as:

chest pain or pressure;
pain spreading to your jaw or shoulder; or
nausea, sweating, general ill feeling.

GTN Sorbitrate-CR can cause severe headaches, especially when you first start using it. These headaches may gradually become less severe as you continue to use GTN Sorbitrate-CR. Do not stop taking this medicine. Ask your doctor before using any headache pain medication.
Call your doctor at once if you have:

severe or throbbing headaches that do not become less severe with continued use of GTN Sorbitrate-CR;
pounding heartbeats or fluttering in your chest;
slow heart rate;
blurred vision or dry mouth; or
a light-headed feeling, like you might pass out.

Common side effects may include:

mild burning or tingling with the tablet in your mouth;
headache;
dizziness, spinning sensation;
nausea, vomiting;
flushing (warmth, redness, or tingly feeling);
pale skin, increased sweating; or
feeling weak or dizzy.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)

GTN Sorbitrate-CR dosing

Usual Adult Dose for Angina Pectoris:

For relief of acute anginal attack:
Lingual spray: 1 to 2 sprays onto or under the tongue every 3 to 5 minutes as needed, up to 3 sprays in 15 minutes. If pain persists after the maximum number of doses, prompt medical attention is recommended.
Sublingual tablet: 0.3 to 0.6 mg dissolved under the tongue or in the GTN Sorbitrate-CR pouch every 5 minutes as needed, up to 3 doses in 15 minutes. If pain persists after the maximum number of doses, prompt medical attention is recommended.
IV continuous infusion (via non PVC tubing): 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed, up to a usual maximum of 200 and generally no more than 400 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Angina Pectoris Prophylaxis:

Lingual spray: 1 to 2 sprays (0.4 to 0.8 mg) onto or under the tongue 5 to 10 minutes prior to engaging in activities which might precipitate an acute attack
Sublingual tablet: 0.3 to 0.6 mg dissolved under the tongue or in the GTN Sorbitrate-CR pouch 5 to 10 minutes prior to engaging in activities which might precipitate an acute attack
Topical ointment: 1/2 inch initially, applied to a non hairy area of the trunk every 6 to 8 hours during waking hours (2 times a day); titrate as needed and tolerated. If angina occurs while the ointment is in place, the dose should be increased; if angina occurs several hours after application, the dosing frequency should be increased. Usual range is 1/2 to 2 inches (7.5 to 30 mg) every 8 hours, typically applied to 36 square inches of truncal skin.
Transdermal patch: 0.1 to 0.4 mg/hr patch applied to a dry and hairless area of the upper arm or body for 12 to 14 hours per day; titrate as needed and tolerated up to 0.8 mg/hr. Application sites should be rotated to avoid skin irritation.
Transmucosal (buccal) tablet: 1 mg dissolved between the lip and gum above the upper incisors or between the cheek and gum every 3 to 5 hours during waking hours (approximately 3 times a day); titrate as needed and tolerated. If angina occurs while a tablet is in place, the dose should be increased to the next strength; if angina occurs after dissolution of tablet, the dosing frequency should be increased. Usual maintenance dosage is 2 mg three times a day. If an acute attack occurs while a tablet is in place, another tablet may be administered on the opposite side from the one already in place. Sublingual GTN Sorbitrate-CR is recommended if prompt relief is not attained.
Oral: 2.5 every 8 to 12 hours; titrate as needed and tolerated up to 9 mg every 8 to 12 hours
Because tolerance to GTN Sorbitrate-CR may develop if plasma levels are maintained continuously, a nitrate free interval of 10 to 12 hours per day may be appropriate during chronic prophylaxis of angina pectoris. However, clinical studies suggest that such intermittent use may be associated with hemodynamic rebound during drug withdrawal and decreased exercise tolerance during the latter part of the nitrate free interval. Although the clinical relevance of this observation is unknown, a potentially increased risk of anginal attack during the nitrate free interval should be considered. Therefore, dosing regimens should be carefully individualized to each patient. Other antianginal drugs such as beta-blockers and calcium channel blockers may be prescribed to reduce the risk of aggravating myocardial ischemia during the drug free intervals.

Usual Adult Dose for Congestive Heart Failure:

Topical ointment: 1/2 inch initially, applied to a non hairy area of the trunk every 6 to 8 hours during waking hours ; titrate as needed and tolerated. Usual range is 1/2 to 2 inches (7.5 to 30 mg) every 8 hours, typically applied to 36 square inches of truncal skin.
Transdermal patch: 0.1 to 0.4 mg/hr patch applied to a dry and hairless area of the upper arm or body for 12 to 14 hours per day; titrate as needed and tolerated up to 0.8 mg/hr. Application sites should be rotated to avoid skin irritation.
Transmucosal (buccal) tablet: 1 mg dissolved between the lip and gum above the upper incisors or between the cheek and gum every 3 to 5 hours during waking hours (approximately 3 times a day); titrate as needed and tolerated. Usual maintenance dosage is 2 mg three times a day.
Oral: 2.5 every 8 to 12 hours; titrate as needed and tolerated up to 9 mg every 8 to 12 hours

Usual Adult Dose for Myocardial Infarction:

For the initial 24 to 48 hours after an acute myocardial infarction:
IV continuous infusion (via non PVC tubing): 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed up to a usual maximum of 200 and generally no more than 400 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Hypertension:

IV continuous infusion : 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed up to a usual maximum of 100 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Anal Fissure and Fistula:

For the treatment of moderate to severe pain associated with chronic anal fissure:
Apply 1 inch of ointment (375 mg of ointment equivalent to 1.5 mg of GTN Sorbitrate-CR) intra anally every 12 hours for up to 3 weeks.

Usual Pediatric Dose for Hypertension:

Perioperative hypertension or induction of intraoperative hypotension:
IV continuous infusion: 0.25 to 0.5 mcg/kg/min initially, increase by 0.5 to 1 mcg/kg/min every 3 to 5 minutes as needed up to 5 mcg/kg/min. Usual dose is 1 to 3 mcg/kg/min, but doses as high as 20 mcg/kg/min have been used.

Active ingredients: Nitroglycerin

Select the most affordable brand or generic drug

Strength	Quantity	Price, USD	Country
10 ML TNG 5 MG/ML Injection
24 HR NTG 0.2 MG/HR Transdermal Patch [Minitran]
24 HR NTG 0.2 MG/HR Transdermal System [Nitro-Dur]
24 HR NTG 0.8 MG/HR Transdermal Patch [Nitro-Dur]
24 HR Nitro-Dur 0.2 MG/HR Transdermal Patch
24 HR Nitroglycerin 0.1 MG/HR Transdermal System [Minitran]
24 HR Nitroglycerin 0.3 MG/HR Transdermal Patch
24 HR Nitroglycerin 0.6 MG/HR Transdermal System [Minitran]
24 HR TNG 0.1 MG/HR Transdermal System
24 HR TNG 0.2 MG/HR Transdermal Patch [Nitro-Dur]
24 HR TNG 0.6 MG/HR Transdermal System
250 ML NTG 0.1 MG/ML Injection
500 ML TNG 0.1 MG/ML Injection
Angiderm
Cardiotec
Glyceryl Trinitrate-Hameln
Glynit (25 mg)
0 .5mg	10 Tablet	$0.25
Glynit 0.5 mg Tablet		$0.03
Glynit 25mg x 5mL INJ / 5mlx5		$3.50
Glynit 6.4mg Tablet		$0.09	Mission Research Laboratories Pvt Ltd
Lycinate
Minitran 0.2 MG/HR 24 HR Transdermal Patch
Minitro
NTG 0.004 MG/MG Rectal Ointment
NTG 0.4 MG/ACTUAT Mucosal Spray [NitroMist]
Nglong
Nglong 2.5 mg Capsule		$0.03
NGLONG modified-release cap 2.5 mg x 10's		$0.31	Novartis (Sandoz)
2 .5 mg x 100's		$3.08
Nglong 2.5mg CAP / 100		$3.08
Nglong 6.5 mg Capsule		$0.04
NGLONG modified-release cap 6.5 mg x 10's		$0.45	Novartis (Sandoz)
6 .5 mg x 100's		$4.48
Nglong 6.5mg CAP / 100		$4.48
Niglinar
Nitrile Gloves
heavyduty	10	$60.56	Australia, Canada, India, Mauritius, NZ, Turkey, Singapore, UK, USA
heavyduty	10	$60.56	Australia, Canada, India, NZ, Turkey, Singapore, UK, USA
large	100	$25.15	Canada, India, NZ, Singapore, Turkey, UK, USA
large	100	$32.48	Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
medium	100	$32.48	Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
small	100	$25.09	Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
small	100	$32.16	Australia, Canada, NZ, Singapore, Turkey, UK, USA
Nitro
2000 .4/1200ds	1 saer	$30.61	Canada, UK
NITRO cap 100 mg x 10's		$1.40	West-Coast
Nitro 2.6mg Tablet		$0.06	Three Dots Lifescience
Nitro-Dur 0.1 MG/HR 24HR Transdermal System
Nitro-Dur 7.5 MG per 24HR Daily Transdermal Patch
Nitrocap
Nitrocor
Nitroderm Matrix
Nitroglicerin Bioindustria L.I.M.
Nitroglicerin Srbolek
Nitroglicerin?
Nitroglicerina
Nitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid]
Nitroglycerin 0.6 MG Sublingual Tablet
Nitroglycerin Slovakofarma
Nitroglycerin Terumo
Nitroglycerin spray
Nitroglycerine Sandoz
Nitrolingual
0 .4mg	1	$27.90	Australia, Canada, NZ, Singapore, Turkey
0 .4mg	3	$52.90	Australia, Canada, NZ, Singapore, Turkey
Nitrolingual 0.4mg Spray		$6.30	Modi Mundi Pharma Pvt Ltd
NITROLINGUAL 0.4MG SPRAY 1 packet(s) (200 MDI spray each)		$6.30	Modi Mundi Pharma Pvt Ltd
Nitrolingual 400 mcg/1 puff x 15 mL		$8.50
Nitrolingual 0.4 MG/ACTUAT Mucosal Spray
Nitromak Retard
Nitromint retard
Nitronal Aqueous
Nitrospray
Olcon
OLCON CR tab 2.6 mg x 50's		$1.82	Olcare (Cardium)
Olcon 2.6mg TAB / 50		$1.82
OLCON CR tab 6.4 mg x 50's		$2.45	Olcare (Cardium)
Olcon 6.4mg TAB / 50		$2.45
Supranitrin
TNG 0.004 MG/MG Rectal Ointment
TNG 0.4 MG/ACTUAT Mucosal Spray [NitroMist]
Transderm - V
1 .5mg	1	$23.99	Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
1 .5mg	1	$23.99	Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
1 .5mg	1	$23.99	Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
1 .5mg	1	$23.99	Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
1 .5mg	5	$69.99	Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
1 .5mg	18 patches	$139.99	Canada, Mauritius, Singapore, Turkey, UK, USA
1 .5mg	18 patches	$139.99	Canada, Mauritius, Singapore, Turkey, UK, USA
1 .5mg	20 patches	$155.49	Canada, Mauritius, Singapore, Turkey, UK, USA
1 .5mg	20 patches	$155.49	Canada, Mauritius, Singapore, Turkey, UK, USA
Trinitrine Simple Laleuf
Trinitrosan
nitroglycerin 0.4 MG/HR 24HR Transdermal System
nitroglycerin 25 MG per 250 ML Injection
nitroglycerin 400 MCG/ACTUAT Sublingual Spray

References

Dailymed."Nitroglycerin: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
"Nitroglycerin". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
"Nitroglycerin". http://www.drugbank.ca/drugs/DB0072... (accessed August 28, 2018).

GTN Sorbitrate-CR - Frequently asked Questions

Can GTN Sorbitrate-CR be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take GTN Sorbitrate-CR?

You should not use GTN Sorbitrate-CR if you are allergic to it, or if:

you are using medicine to treat pulmonary arterial hypertension, such as riociguat (Adempas), sildenafil (Revatio), or tadalafil (Adcirca).

Do not take erectile dysfunction medicine (Viagra, Cialis, Levitra, Stendra, Staxyn, sildenafil, avanafil, tadalafil, vardenafil) while you are taking GTN Sorbitrate-CR. Using erectile dysfunction medicine with GTN Sorbitrate-CR can cause a sudden and serious decrease in blood pressure.

You should not use sublingual GTN Sorbitrate-CR if you have:

severe anemia (low red blood cells);
a head injury, brain tumor, or other condition that causes increased pressure inside the skull; or
early signs of a heart attack (chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating, general ill feeling).

To make sure GTN Sorbitrate-CR is safe for you, tell your doctor if you have:

congestive heart failure;
heart rhythm disorder (especially if you take medicine to treat this condition);
a history of heart attack, stroke, or head injury;
low blood pressure;
glaucoma;
migraine headaches; or
if you are dehydrated.

FDA pregnancy category C. It is not known whether GTN Sorbitrate-CR will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

It is not known whether GTN Sorbitrate-CR passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

How should I take GTN Sorbitrate-CR?

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended. Keep this medicine on hand at all times in case of an angina attack. Get your prescription refilled before you run out of medicine completely.

GTN Sorbitrate-CR is usually taken at the first sign of chest pain. If possible, try to rest or stay seated when you use this medication. GTN Sorbitrate-CR can cause dizziness or fainting.

You may use GTN Sorbitrate-CR sublingual within 5 to 10 minutes before an activity you think might cause chest pain. Follow your doctor's instructions.

If you use GTN Sorbitrate-CR sublingual spray to treat an angina attack: At the first sign of an attack, apply the spray directly on or under your tongue. Close your mouth after each spray. Do not inhale the spray. Do not shake the spray before or during use. You may use additional sprays every 5 minutes, but not more than 3 sprays in 15 minutes.

The GTN Sorbitrate-CR sublingual tablet should be placed under your tongue and allowed to dissolve slowly. Do not chew or swallow it. You may use additional tablets every 5 minutes, but not more than 3 tablets in 15 minutes.

Seek emergency medical attention if your chest pain gets worse or lasts more than 5 minutes, especially if you have trouble breathing or feel weak, dizzy, or nauseated, or lightheaded.

You may feel a slight burning or stinging in your mouth when you use this medicine. However, this sensation is not a sign of how well the medication is working. Do not use more medication just because you do not feel a burning or stinging.

Do not crush, chew, break, or open an extended-release capsule. Swallow it whole.

This medicine can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using GTN Sorbitrate-CR.

If you take GTN Sorbitrate-CR on a regular schedule to prevent angina, do not stop taking it suddenly or you could have a severe attack of angina.

Store the tablets in the glass container at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use.

Keep the spray away from open flame or high heat, such as in a car on a hot day. The canister may explode if it gets too hot.

What other drugs will affect GTN Sorbitrate-CR?

Many drugs can interact with GTN Sorbitrate-CR. Not all possible interactions are listed here. Tell your doctor about all your medications and any you start or stop using during treatment with GTN Sorbitrate-CR, especially:

aspirin or heparin;
a diuretic or "water pill";
medicine to treat depression or mental illness; or
ergot medicine to treat migraine headache, such as dihydroergotamine, ergotamine, ergonovine, or methylergonovine.

This list is not complete and many other drugs can interact with GTN Sorbitrate-CR. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.

Can GTN Sorbitrate-CR be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can GTN Sorbitrate-CR be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on GTN Sorbitrate-CR, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of GTN Sorbitrate-CR. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.